Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 72,806 $ 118,575
Short-term restricted cash 1,419 1,003
Accounts receivable, net 46,122 85,464
Inventory 78,104 90,343
Prepaid expenses and other current assets 50,390 28,057
Total current assets 248,841 323,442
Long-term restricted cash 27,187 25
Property and equipment, net 48,873 59,300
Leased right-of-use assets 15,506 18,184
Intangible assets, net 48,892 55,008
Goodwill 318,588 318,588
Deferred tax assets 77,268 68,662
Other long-term assets 11,241 21,430
Total assets 796,396 864,639
Current liabilities:    
Accounts payable 37,916 31,378
Accrued price protection liability 26,493 43,401
Accrued expenses and other current liabilities 72,392 87,408
Accrued compensation 49,219 20,097
Total current liabilities 186,020 182,284
Long-term lease liabilities 12,313 16,952
Long-term debt 123,618 122,996
Other long-term liabilities 22,550 26,124
Total liabilities 344,501 348,356
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 86,451 shares issued and outstanding at December 31, 2025 and 84,613 shares issued and outstanding December 31, 2024 9 8
Additional paid-in capital 951,262 886,823
Accumulated other comprehensive income (loss) 1,030 (6,823)
Accumulated deficit (500,406) (363,725)
Total stockholders’ equity 451,895 516,283
Total liabilities and stockholders’ equity $ 796,396 $ 864,639